Zhejiang Yichenkang Biotechnology
Zhejiang Yichenkang Biotechnology's purity-focus record is strongest on Ipamorelin and GHK-Cu, while BPC-157 and Semaglutide show the clearest weak spots. The evidence is recent and moderate in volume, but results are dispersed rather than clearly improving, with sub-99.5% purity misses, fill swings, and absent batch IDs limiting traceability.
We investigated who actually operates Zhejiang Yichenkang Biotechnology — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Zhejiang Yichenkang Biotechnology rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 11 Dec 2025 | Pass | Retatrutide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 5 Dec 2025 | Pass | Tirzepatide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 2 Dec 2025 | Fail | Retatrutide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 25 Nov 2025 | Pass | Retatrutide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 17 Oct 2025 | Pass | Retatrutide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 20 Sep 2025 | Fail | GHK-Cu Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 20 Sep 2025 | Pass | GHK-Cu Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 5 Sep 2025 | Pass | Ipamorelin Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 5 Sep 2025 | Pass | Ipamorelin Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
| 5 Aug 2025 | Fail | Semaglutide Zhejiang Yichenkang Biotechnology | lab name | View COA | |||
About Zhejiang Yichenkang Biotechnology test results from Finnrick
Zhejiang Yichenkang Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 58 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Zhejiang Yichenkang Biotechnology peptides in this dataset are CJC-1295 (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 58 recent tests.